- Loss of exclusivity for key brands Eliquis and Zavicefta.
- Revision of the National List of Essential Medicines (NLEM-2022) and consequent expansion of drugs under price controls.
- Transition to a new Go-To-Market model.
- Impending generic competition.
Pfizer Limited
Carbon Emissions & Sustainability Report
CO₂ Emissions
3.4K tons/year (Scope 1 and 2)
2022-04 to 2023-03
Renewable Energy
13%
of total energy
Water Usage
35.3K kilolitres/year
2022-04 to 2023-03
Waste
166.90 metric tons/year
2022-04 to 2023-03
Energy Use
662 MWh/year (renewable)
2022-04 to 2023-03
📊 Emissions Breakdown (2022-04 to 2023-03)
Scope 1
Direct emissions
63 tCO2e/year
Scope 2
Electricity
3.7K tCO2e/year
📈 Historical Emissions
2022-04 to 2023-03
3.4K tons/year (Scope 1 and 2)
2018-04 to 2019-03
Not available
✅ Key Environmental Achievements
- Reduced greenhouse gas emissions by 8.7% at the Goa plant despite a 6% increase in production volumes.
- Achieved ~13% of total energy demand for manufacturing operations at the Goa plant from renewable sources.
🎯 Future Goals
📅 Medium-term
- Increase women representation in field force to 15%.
🔭 Long-term
- Achieve Net-Zero emissions by 2040 (aligned with Pfizer Inc.'s goal).
🌱 ESG Focus Areas
Environmental SustainabilityDiversity, Equity & InclusionEthical OperationsAccess to MedicinesAntimicrobial Resistance